Key facts
- This page summarizes Tyler Lipschultz's Form 4 filing for SeaSpine Holdings Corp.
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 04 Jan 2022, 20:22.
Tyler Lipschultz - 01 Jan 2022 Form 4 Insider Report for SeaSpine Holdings Corp
- Reporting relationship
- SVP, Orthobiologics and BD
- Issuer ticker
- N/A
- Reported as of
- 01 Jan 2022
- Net transaction value
- -$65,390
- SEC form
- 4
- Accepted by SEC
- 04 Jan 2022, 20:22:41 UTC
- Prior SEC filing
- 02 Jul 2021
- Next SEC filing
- 01 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/Paul Benny, Attorney-in-Fact for Tyler Lipschultz
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Tyler Lipschultz filed Form 4 for SeaSpine Holdings Corp on 04 Jan 2022.
Change
- Previous filing in this sequence was filed on 02 Jul 2021.
- Current net transaction value: -$65,390.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SPNE
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +3,564
- Change %
- +3.2%
- Price
- Shares after
- 116,031
- Date
- 01 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
SPNE
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +8,362
- Change %
- +7.2%
- Price
- Shares after
- 124,393
- Date
- 01 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
SPNE
transaction
Common Stock
Tax liability
- Transaction value
- $65,390
- Shares
- -4,801
- Change %
- -3.9%
- Price
- $13.62
- Shares after
- 119,592
- Date
- 01 Jan 2022
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SPNE
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -3,564
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 01 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,564
- Exercise price
- Footnotes
- F1, F3
SPNE
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -8,362
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 8,362
- Date
- 01 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,362
- Exercise price
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
Footnote F2
These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2022. No shares were sold in connection with this transaction.
Footnote F3
The reporting person was granted 10,691 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022.
Footnote F4
The reporting person was granted 25,086 restricted stock units on January 1, 2020, which vest in three equal installments on each of January 1, 2021, 2022 and 2023.